openPR Logo
Press release

The Chinese biopharmaceutical contract manufacturing market is estimated to be worth USD 2.6 billion in 2030, predicts Roots Analysis

01-12-2021 01:52 PM CET | Health & Medicine

Press release from: Roots Analysis

The Chinese biopharmaceutical contract manufacturing market

The growing biopharma industry in China has resulted in the creation of lucrative business opportunities for contract service providers; region-specific advantages have also attracted several foreign sponsors entities over the last few years

Roots Analysis is pleased to announce the publication of its recent study, titled, “China Biopharmaceutical Contract Manufacturing Market, 2020-2030.”

For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/china-biopharmaceutical-contract-manufacturing/313.html

The report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of biopharmaceuticals in China. The study also features a detailed analysis of key drivers and trends related to this evolving domain. In addition to other elements, the study includes:
A detailed assessment of the current market landscape of companies offering contract manufacturing services for biopharmaceuticals in China.
An analysis of the partnerships that have been established in this domain, in the recent past.
An analysis of the expansion initiatives undertaken by contract manufacturers in China, in order to augment their capabilities, in the recent past.
A detailed analysis of more than 1500 clinical trials related to biopharmaceuticals that have been / are being / are likely to be conducted in China.
An estimate of the overall, installed capacity for manufacturing biopharmaceuticals, based on data reported by industry stakeholders in the public domain.
An analysis of the initiatives of big biopharma players engaged in this domain.
A qualitative analysis, highlighting the various factors that need to be taken into consideration by drug / therapy developers while deciding whether to manufacture their respective products in-house or engage the services of a CMO.
Detailed profiles of key players that have a diverse range of capabilities for the development, manufacturing, and packaging of biopharmaceutical products.
A case study comparing the key characteristics of large molecule and small molecule drugs.
A discussion on industry affiliated trends, key drivers, and challenges, under a SWOT framework, which are likely to impact the evolution of this field.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Type of Product
API
FDF
Type of Expression System Used
Mammalian
Microbial
Others
Scale of Operation
Preclinical / Clinical
Commercial
Size of Manufacturer
Small
Mid-sized
Large / Very Large
Type of Biologic
Antibody
Vaccine
Others

Key companies covered in the report
ChemPartner Biologics
JHL Biotech
JOINN Biologics
MabPlex
Mycenax Biotech
WuXi AppTec

For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/china-biopharmaceutical-contract-manufacturing/313.html

Other Recent Offerings
1. China Pharmaceutical Contract Manufacturing Services Market, 2020-2030
2. Live Biotherapeutics Products and Microbiome Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020-2030
3. Oligonucleotide Synthesis, Modification and Purification Services Market: Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030

Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com

Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Chinese biopharmaceutical contract manufacturing market is estimated to be worth USD 2.6 billion in 2030, predicts Roots Analysis here

News-ID: 2223927 • Views:

More Releases from Roots Analysis

T-Cell Therapy Market Size to Hit USD 20.9 billion by 2035| Exclusive Report by Roots Analysis
T-Cell Therapy Market Size to Hit USD 20.9 billion by 2035| Exclusive Report by …
Cancer is one of the leading causes of mortality across the world. As per the International Agency for Research on Cancer (IARC), by 2040, there are likely to be 27.5 million new cases and 16.3 million deaths related to cancer, annually. Although cancer therapeutics continue to be one of the most active areas, in terms of drug development, there is still a significant unmet need in this domain. In fact,
Cancer Biologics Market: Unmet Need and Treatment Guidelines
Cancer Biologics Market: Unmet Need and Treatment Guidelines
Owing to the increasing mortality rates and growing need for novel modalities to treat oncological disorders, several researchers and industry stakeholders have shifted their focus on the development of safe and effective biologic therapies. Cancer biologics are the class of therapeutic agents, which primarily modulate immune responses or directly inhibits oncogenic pathways in malignancies. These therapies, such as monoclonal antibodies, specifically target tumor-activating genes, facilitate antibody-dependent cellular cytotoxicity and complement
Peptide Synthesis: Supporting Next Generation Targeted Therapies
Peptide Synthesis: Supporting Next Generation Targeted Therapies
Peptides are specialized molecules composed of short chains of amino acids and are used primarily as the active ingredients in a new class of targeted therapeutics. Peptide synthesis is achieved through various advanced methodologies, including chemical processes like solid-phase (SPPS) and liquid-phase (LPPS), as well as hybrid and non-chemical approaches. Peptides are being extensively used as therapeutics to treat various disorders, including metabolic diseases, oncological disorders, and hormonal imbalances due to
Prefilled Syringes Market Size to Hit USD 4.97 billion by 2035| Exclusive Report by Roots Analysis
Prefilled Syringes Market Size to Hit USD 4.97 billion by 2035| Exclusive Report …
Prefilled syringes: setting new standards for safe and efficient drug administration. With the increasing population, the incidence rates of various chronic diseases, such as diabetes, autoimmune disorders, cardiovascular disorders and oncological disorders, are witnessing an upward trend. The global prefilled syringes market, valued at USD 3.02 billion in 2024, is project to reach USD 3.19 billion in 2025 and USD 4.97 billion by 2035, representing a CAGR of 4.5% during the

All 5 Releases


More Releases for China

China fund establishment, China fund management,china investment management
Pandacu China is a leading financial institution that specializes in providing fund establishment and management services for domestic and international investors looking to invest in China. The company was founded in 2015 by a team of experienced finance professionals with a deep understanding of the Chinese market and a strong network of contacts in the investment industry. https://boomingfaucet.com/ China Fund Establishment Consultation E-mail:nolan@pandacuads.com Investing in China can be a complex and challenging process, and
China Finance Advisor, China Debt Finance Corporation,China Investment Corporati …
Investment bank is a financial institution that helps companies and governments raise capital by underwriting and issuing securities, and also provides advice on mergers and acquisitions, strategic investments, and other financial matters. Investment banks typically have a team of professionals with expertise in various areas such as corporate finance, securities underwriting, sales and trading, and market research. http://pandacuads.com/ China Investment Corporation Email:nolan@pandacuads.com Some of the main services provided by investment banks include: Underwriting: Investment banks
China Investment Bank, China Investment Consultant, China Investment Corporation …
Pandacu is a company that specializes in cross-border investment in China. The company was founded in china and has since grown to become one of the leading cross-border investment firms in China. Pandacu offers a wide range of services to its clients, including investment advisory, market research, due diligence, and post-investment support. http://pandacuads.com/ Investment banking consultant Email:nolan@pandacuads.com Cross-border investment in China can be a complex and challenging process, as the country has a unique
china construction company,china engineering company,china major bridge engineer …
List of Top 500 Chinese Construction Enterprises ranking https://gzwatches.cn/ Free engineering construction consultation Email:nolan@wholsale9.com Company Name province 1 China State Construction Corporation Limited Beijing 2 China Railway Corporation Limited Beijing 3 China Railway Construction Corporation Limited Beijing 4 Shanghai Weimengsi Construction Engineering Co., Ltd. Shanghai 5 China Communications Construction Group Co., Ltd. Beijing 6 China Power Construction Corporation Limited Beijing 7 China Energy Construction Group Co., Ltd. Beijing 8 Shanghai Construction Engineering Group Co., Ltd. Shanghai 9 Jiangsu Zhongnan Construction Industry Group Co., Ltd. Jiangsu 10 China Gezhouba Group Co., Ltd. Hubei 11 China National Chemical Engineering Co., Ltd. Beijing 12 Sinoma Group Co., Ltd. Beijing 13 Guangxi Construction Engineering Group Co., Ltd. Guangxi 14 Shanghai Urban
Forehead Thermometer Market Analysis (2019- 2025)| Microlife (China), Radiant (C …
This research study is one of the most detailed and accurate ones that solely focus on the global Forehead Thermometer market. It sheds light on critical factors that impact the growth of the global Forehead Thermometer market on several fronts. Market participants can use the report to gain a sound understanding of the competitive landscape and strategies adopted by leading players of the global Forehead Thermometer market. The authors of
Global Color Steel Tile Market 2017 - South China, East China, Southwest China, …
Color Steel Tile Market Research Report A market study based on the " Color Steel Tile Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Color Steel Tile Market 2017’. The research report analyses the historical as well as present performance of the worldwide Color Steel Tile industry, and makes predictions on the future status of Color Steel Tile market on the basis